Lymphokine activateed killer (LAK) cell-mediated lysis of murine glioma: trypsinchymotrypsin-sensitive glioma protein is responsible for tumor-selective recognition by LAK cells

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Elizabeth A. Grimm, A Mazumder, H Z Zhang et al. · The Journal of Experimental Medicine · 1982 · 2.2K citations · Full text

Life Sciences, Immunology, Oncology +15

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas

Michael Walker, Eben Alexander, William E. Hunt et al. · Journal of neurosurgery · 1978 · 1.7K citations

Medicine, Oncology, Radiation Oncology +11

Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after Surgery

Michael Walker, Sylvan B. Green, David P. Byar et al. · New England Journal of Medicine · 1980 · 1.6K citations

Medicine, Oncology, Radiation Oncology +9

Biological Activity of Recombinant Human Interleukin-2 Produced in <i>Escherichia coli</i>

Steven A. Rosenberg, Elizabeth A. Grimm, Michael McGrogan et al. · Science · 1984 · 599 citations

Life Sciences, Cell Biology, Immunology +15

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

EA Grimm, KM Ramsey, A Mazumder et al. · The Journal of Experimental Medicine · 1983 · 469 citations · Full text

Life Sciences, Immunology, Oncology +14